What We're Reading: Page 139
Industry reads hand-picked by our editors
Dec 03, 2021
-
The Wall Street Journal
FDA Aims for Quick Review of Omicron Vaccines and Drugs
-
STAT
Califf asks Woodcock to stay in FDA leadership role if he’s confirmed
-
Financial Times
Fujifilm to double size of Teesside plant that makes Covid vaccine
-
Evaluate Vantage
Bridgebio sets its heart on besting Pfizer
Dec 02, 2021
-
STAT
Biden's new Covid plan: more boosters, free home testing, and 'monoclonal antibody strike teams'
-
Reuters
Australia's CSL in exclusive talks to buy Swiss Vifor Pharma - report
-
The Atlantic
What the J&J Vaccine Can Still Teach Us
-
JAMA
After 12 Years, NIH Director Francis S. Collins Seeks His Next Chapter
Dec 01, 2021
-
The New York Times
South African Company Nears License to Sell J. & J. Covid Shot Across Africa
-
Bloomberg
Biogen Loses Bid to Revive Patent on Tecfidera MS Drug
-
FierceBiotech
Sanofi snaps up Origimm for early-phase acne vaccine, opening new front in mRNA strategy
-
Reuters
U.S. FDA declines to approve BeyondSpring's neutropenia drug, shares plunge
Nov 30, 2021
-
Financial Times
The inside story of the Pfizer vaccine: 'a once-in-an-epoch windfall'
-
Evaluate Vantage
Biggest unpartnered assets: Argenx nears crunch time
-
The Washington Post
Pfizer poised to request authorization for coronavirus booster for 16 and 17 year olds
-
Endpoints News
FDA cancels ODAC meeting this week to review two more dangling accelerated approvals — but won’t explain why
Nov 29, 2021
-
Science
'Patience is crucial': Why we won't know for weeks how dangerous Omicron is
-
The Boston Globe
Alnylam getting a rare kind of leader
-
The Wall Street Journal
Drugmakers Gear Up for Price Restrictions in Biden's Legislative Agenda
-
Nature Biotechnology
The CRISPR children
Nov 24, 2021
Nov 23, 2021
-
Business Insider
Gene Editing Pioneer David Liu Developing Drug to Prevent Alzheimer's
-
Reuters
EQT, BioNTech investor consider bid for Novartis arm Sandoz - report
-
STAT
Sherif Zaki, a legendary disease detective at CDC, dies at 65
-
FierceBiotech
Founder-led biotech is making space for ideas—and diverse leaders—where it didn't exist before
Previous
